Case 2:15-cvDocument 1 FiledPage 1 of 46 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA IN RE: XARELTO (RIVAROXABAN)

First Page		Document Content
Date: 2015-04-29 22:26:38 Bayer IG Farben Leverkusen Mauthausen-Gusen concentration camp Nutrition Schering AG Schering Ortho-McNeil-Janssen Rivaroxaban Economy of Germany Germany Medicine		Case 2:15-cvDocument 1 FiledPage 1 of 46 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA IN RE: XARELTO (RIVAROXABAN) Add to Reading List Source URL: www.aboutlawsuits.com Download Document from Source Website File Size: 743,88 KB Share Document on Facebook

	Case 2:15-cvDocument 1 FiledPage 1 of 46 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA IN RE: XARELTO (RIVAROXABAN) DocID: 1aXpW - View Document
	March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-Mc DocID: Mj7H - View Document
	Kentucky Medicaid Pharmacy 3Q2011 Active Labelers List Labeler ID Labeler Name DocID: L8ds - View Document
	McNeil Consumer Healthcare Division of McNeil – PPC, Inc[removed]Camp Hill Road, Fort Washington, PA[removed]-7000 ADDENDUM DocID: FwJP - View Document
	AP PELLA TE LITIGATION RETENTION AGREEMENT FOR SPECIAL COUNSEL APPOINTED BY THE SOUTH CAROLINA ATTORNEY GENERAL AS TO STATE OF SOUTH CAROLINA ex rel. ALAN WILSON, in his capacity as Attorney General/or the State of South DocID: BAyD - View Document